Pharmacogenomic Study to Predict Neurotoxicity of Oxaliplatin
NCT00977717
·
clinicaltrials.gov ↗
COMPLETED
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Curatively Resected Stage III Colon Cancer
Sponsor
Samsung Medical Center